BEGIN:VCALENDAR
VERSION:2.0
PRODID:IEEE vTools.Events//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
DTSTART:20230312T030000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:20231105T010000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20231107T144226Z
UID:935009D1-58A0-4050-8CD2-57701102E4A8
DTSTART;TZID=America/New_York:20231103T130000
DTEND;TZID=America/New_York:20231103T140100
DESCRIPTION:Traumatic events alter the body and the brain. Severe intrusive
  memories are a perpetuating clinical symptom in posttraumatic stress diso
 rder (PTSD). In this talk\, Dr Nil Gurel of Meta Reality Labs\, will discu
 ss a novel\, electroceutical intervention that stimulates the vagus nerve 
 non-invasively\, with no side effects. Her research has combined noninvasi
 ve sensors and signal processing to develop digital biomarkers to guide PT
 SD treatment. The results were found to be sufficiently compelling by the 
 FDA to accelerate the use of non-invasive vagus nerve stimulation (nVNS) a
 s a treatment for PTSD through the Breakthrough Device Program\, which spe
 eds the development of medical devices for the more effective treatment of
  life-threatening or irreversibly debilitating conditions.\n\nSpeaker(s): 
 Dr. Nil Gurel\, \n\nVirtual: https://events.vtools.ieee.org/m/378617
LOCATION:Virtual: https://events.vtools.ieee.org/m/378617
ORGANIZER:cuhadar@ieee.org
SEQUENCE:39
SUMMARY:Coping with Trauma\, Healing PTSD using Biosensor Technologies
URL;VALUE=URI:https://events.vtools.ieee.org/m/378617
X-ALT-DESC:Description: <br /><p>Traumatic events alter the body and the br
 ain. Severe intrusive memories are a perpetuating clinical symptom in post
 traumatic stress disorder (PTSD). In this talk\, Dr Nil Gurel of Meta Real
 ity Labs\, will discuss a novel\, electroceutical intervention that stimul
 ates the vagus nerve non-invasively\, with no side effects. Her research h
 as combined noninvasive sensors and signal processing to develop digital b
 iomarkers to guide PTSD treatment. The results were found to be sufficient
 ly compelling by the FDA to accelerate the use of non-invasive vagus nerve
  stimulation (nVNS) as a treatment for PTSD through the Breakthrough Devic
 e Program\, which speeds the development of medical devices for the more e
 ffective treatment of life-threatening or irreversibly debilitating condit
 ions.</p>
END:VEVENT
END:VCALENDAR